GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veru Inc (STU:FMW) » Definitions » Additional Paid-In Capital

Veru (STU:FMW) Additional Paid-In Capital : €301.01 Mil(As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Veru Additional Paid-In Capital?


Veru's quarterly additional paid-in capital increased from Sep. 2023 (€266.01 Mil) to Dec. 2023 (€296.69 Mil) and increased from Dec. 2023 (€296.69 Mil) to Mar. 2024 (€301.01 Mil).

Veru's annual additional paid-in capital increased from Sep. 2021 (€205.41 Mil) to Sep. 2022 (€256.51 Mil) and increased from Sep. 2022 (€256.51 Mil) to Sep. 2023 (€266.01 Mil).

Veru Additional Paid-In Capital Historical Data

The historical data trend for Veru's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veru Additional Paid-In Capital Chart

Veru Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 100.12 107.80 205.41 256.51 266.01

Veru Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 247.95 255.45 266.01 296.69 301.01

Veru Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Veru Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Veru's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Veru (STU:FMW) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veru Inc (STU:FMW) » Definitions » Additional Paid-In Capital
Comparable Companies
DRTS ATOS TRVI OTLK ACHV BLUE GLSI GALT OBIO CAPR OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
VERU:USA FMW:Germany
Address
2916 North Miami Avenue, Suite 1000, Miami, FL, USA, 33127
Website
https://www.verupharma.com
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.

Veru (STU:FMW) Headlines

No Headlines